Concepedia

Publication | Open Access

A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis

DOIFull Paper Access

74

Citations

19

References

2014

Year

Alex M. Dickens, James R. Larkin, Julian L. Griffin, Ana Cavey, Lucy Matthews, Martin R. Turner, Gordon Wilcock, Benjamin G. Davis, Timothy D. W. Claridge, Jacqueline Palace,
Neurology

Abstract

This study provides Class II evidence that serum metabolite profiles accurately distinguish patients with different subtypes and stages of MS.

References

YearCitations

Page 1